Non classé Archives - Page 7 of 9 - The Central Indiana Corporate Partnership

Governor’s Workforce Cabinet, Conexus Indiana launch grant program to support high school adoption of Industry 4.0 technologies, prepare future workforce

Raquel Bahamonde2022-03-08T09:33:39-05:00March 8, 2022|

(INDIANAPOLIS) - The Governor’s Workforce Cabinet and Conexus Indiana today announced a new $500,000 grant program to support Indiana high schools as they prepare students for careers in the increasingly high-tech advanced manufacturing industry. Modeled after the statewide Manufacturing Readiness Grants program, Education Readiness Grants are available for qualifying secondary schools that purchase new, smart manufacturing technologies and equipment to develop skills students need to succeed in an Industry 4.0 economy. The Education Readiness Grants program is a direct response to the success of the Manufacturing Readiness Grants program, launched in mid-2020 and administered by the Indiana Economic Development Corporation (IEDC) in partnership with Conexus Indiana. To date, 169 awards have been made totaling more than $13.4 million in Manufacturing Readiness Grants. These grants are supporting a projected $93 million in capital investment in Industry 4.0 technologies, which connect physical [...]

CICP and TechPoint Launch Nationwide Search for New President and CEO

Raquel Bahamonde2022-01-25T08:17:10-05:00January 25, 2022|

After nine years of growing CICP's tech initiative TechPoint, President and CEO Mike Langellier recently announced he is stepping down. CICP and TechPoint's Executive Committee have launched a national search for his replacement. Candidates, or those with suggestions for candidates to succeed Langellier, should contact: Robin Goolsbee Robin.Goolsbee@divsearch.com Diversified Search Group To learn more about the position, you can view the job description here.

The First Signpost on the Road from Early Adoption to Widespread Application of Industry 4.0 Technologies

Raquel Bahamonde2021-12-09T09:00:52-05:00December 9, 2021|

Download PDF

Racial Gaps in the Education-to-Workforce Pipeline is Indiana’s Opportunity to Close Them

Raquel Bahamonde2021-11-09T09:50:01-05:00November 9, 2021|

Download PDF

Supporting Life Sciences: A look back at BioCrossroads’ capital strategy

Raquel Bahamonde2022-07-29T14:41:04-04:00October 27, 2021|

Download PDF

ESSENTIAL: The economic impact of Central Indiana’s healthcare and life sciences sector

Raquel Bahamonde2021-08-25T12:44:40-04:00August 25, 2021|

Download PDF

2020 CICP Annual Report

Raquel Bahamonde2021-04-15T15:18:17-04:00April 15, 2021|

Download PDF

Indiana Life Sciences Capital 2020

Raquel Bahamonde2021-04-21T12:32:36-04:00April 12, 2021|

Download PDF

Indiana’s life sciences companies accessed more than $9 billion to grow innovation in 2020 BioCrossroads report details funding sources, deals, investors

Raquel Bahamonde2021-05-05T06:36:06-04:00April 12, 2021|

INDIANAPOLIS (April 12, 2021) -- In 2020, Indiana’s life sciences companies accessed over $9 billion in capital to grow and support innovation. The funding comes from a variety of sources including Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) awards, venture capital, initial public offerings and related public offerings, and mergers and acquisitions. BioCrossroads today issued their annual report, Indiana Life Sciences Capital 2020, which provides details on the funding events throughout the year. The $9 billion includes: $12.6 million SBIR awarded to 21 companies. $262 million in venture capital invested in 44 companies. $141.8 million accessed through public markets by three companies. $8.6 billion+ spent to acquire innovation, representing nine transactions. The market capitalization for Indiana’s public life sciences companies as of Dec. 31, 2020 was $297.6 billion and includes Eli Lilly and Company, Anthem, Zimmer [...]

Indiana’s life sciences industry breaks yearly records in two key categories – exports and venture capital

Raquel Bahamonde2021-04-21T11:21:42-04:00March 25, 2021|

INDIANAPOLIS, (March 25, 2021) -- While COVID-19 continues to make the headlines, Indiana’s life sciences industry not only combatted the pandemic with testing, treatments, clinical trials, and vaccine manufacturing but remained committed to innovating and investing throughout 2020. New data provided to BioCrossroads by the Indiana Business Research Center (IBRC) at the Indiana University Kelley School of Business shows a thriving and growing sector. One of the most notable milestones: Indiana is the second highest exporter of life sciences products in the U.S. and has been for more than a decade. In 2020, more than $11.4 billion of products were exported from the state, representing more than $192,000 of output per worker, the highest amount ever recorded. In addition, Indiana life sciences start-ups garnered a record level of venture capital investment with more than $262 million committed to 44 companies, [...]

MAIN MENU

IMPORTANT LINKS

INITIATIVES